Investors Watch List: Points International Ltd. (NASDAQ:PCOM), ADURO BIOTECH, INC. (NASDAQ:ADRO), Qlik Technologies, Inc. (NASDAQ:QLIK), MGC Diagnostics Corporation (NASDAQ:MGCD), Aegerion Pharmaceuticals (NASDAQ:AEGR)

Points International Ltd. (NASDAQ:PCOM) belongs to Technology sector. Its net profit margin is 2.30% and weekly performance is 19.30%. On last trading day company shares ended up $14.22. Points International Ltd. (NASDAQ:PCOM) distance from 50-day simple moving average (SMA50) is 25.06%. Points International Ltd. (NASDAQ:PCOM) announced that members of management participated in the Benchmark Company, LLC One-on-One Investor Conference 2015 held Thursday, May 28th at the Pfister Hotel in Milwaukee, Wisconsin.

ADURO BIOTECH, INC. (NASDAQ:ADRO) shares advanced 1.81% in last trading session and ended the day at $32.08. ADRO return on assets is -78.50%. William Blair started coverage on shares of Aduro BioTech (NASDAQ:ADRO) in a research report released on Monday morning, reports. The firm issued an outperform rating on the stock.

On 27 May, Qlik Technologies, Inc. (NASDAQ:QLIK) shares advanced 1.14% and was closed at $36.85. QLIK EPS growth in last 5 year was -45.40%. Qlik Technologies, Inc. (NASDAQ:QLIK) year to date (YTD) performance is 19.31%. Qlik Technologies, Inc. (NASDAQ:QLIK) announced that its Chief Financial Officer Tim MacCarrick will present at the William Blair 2015 Growth Stock Conference in Chicago on June 10, 2015 at 10:40 a.m. Central Time.

MGC Diagnostics Corporation (NASDAQ:MGCD) ended the last trading day at $6.00. Company weekly volatility is calculated as 8.09% and price to cash ratio as 4.83. MGC Diagnostics Corporation (NASDAQ:MGCD) showed a weekly performance of -0.83%. MGC Diagnostics Corporation (NASDAQ: MGCD), scheduled a conference call to discuss its financial results for the second quarter of fiscal 2015, ended April 30, 2015. The call will be at 4:30 p.m. ET on Tuesday, June 2, 2015. T

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) shares fell -1.69% in last trading session and ended the day at $19.82. AEGR Gross Margin is 87.70% and its return on assets is -11.30%. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) quarterly performance is -26.62%. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), announced that the company will participate in the Jefferies 2015 Healthcare Conference in New York City. Marc Beer, Chief Executive Officer of Aegerion, is scheduled to present on Tuesday, June 2, 2015 at 3:00 p.m. ET.

Leave a Reply

Your email address will not be published. Required fields are marked *